Cite
MLA Citation
Olivier Chabre et al.. “Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence.” Lancet, vol. 10, no. 6, 2022, pp. 384–385. http://access.bl.uk/ark:/81055/vdc_100155153492.0x00000f
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Olivier Chabre et al.. “Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence.” Lancet, vol. 10, no. 6, 2022, pp. 384–385. http://access.bl.uk/ark:/81055/vdc_100155153492.0x00000f